Abivax (ABVX) Non Operating Income (2024 - 2026)
Abivax (ABVX) posted quarterly Non Operating Income of $9.4 million for Q1 2026, up 271.99% year-over-year from $2.5 million in Q1 2025, and up 279.96% quarter-over-quarter from -$5.2 million in Q4 2025.
Abivax (ABVX) Non Operating Income (2024 - 2026) Analysis & Trends
Abivax's Non Operating Income history runs 3 years deep, the most recent figure standing at $9.4 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 271.99% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at -$82.9 million (down 649.4% YoY), while the FY2025 annual figure was -$98.0 million, down 2679.42% from the prior year.
- Non Operating Income for Q1 2026 stood at $9.4 million, up from -$5.2 million in the prior quarter.
- The five-year high for Non Operating Income was $9.4 million in Q1 2026, with the low at -$84.9 million in Q3 2025.
- The 3-year median for Non Operating Income is -$3.7 million (2024), against an average of -$10.2 million.
- The sharpest annual moves came in 2025 and 2026: Non Operating Income tumbled 1435.29% in 2025, then jumped 271.99% in 2026.
- Abivax's Non Operating Income stood at $3.6 million in 2024, then sank by 243.94% to -$5.2 million in 2025, then soared by 279.96% to $9.4 million in 2026.
- Business Quant data shows ABVX's Non Operating Income at $9.4 million in Q1 2026, -$5.2 million in Q4 2025, and -$84.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | 9.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.35 Mn |
| Dec 31, 2025 | -5.20 Mn |
| Sep 30, 2025 | -84.93 Mn |
| Jun 30, 2025 | -2.17 Mn |
| Mar 31, 2025 | -5.44 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | -5.53 Mn |
| Jun 30, 2024 | -3.71 Mn |
| Mar 31, 2024 | 1.96 Mn |